Skip to main content

$21.37 0.02 (0.09%)

High

$21.50

Low

$21.07

Trades

54

Turnover

$305,963

Volume

14,319
30 June 2023 at 4:24pm
Register to track AVR and receive email alerts.
Subject
AVR Ann: Agreement to Develop New Heart Valve Repair Device

AVR Ann: Corporate Governance Statement and Appendix 4G

AVR Ann: Annual Report to shareholders

AVR Ann: Patent for Transcatheter Heart Valve Replacement Technology

AVR Ann: Becoming a substantial holder from MUFG

AVR Ann: Ceasing to be a substantial holder from MUFG

AVR Ann: Becoming a substantial holder for MS

AVR Ann: Ceasing to be a substantial holder from MS

AVR Ann: Becoming a substantial holder from MUFG

AVR Ann: Becoming a substantial holder from MS

AVR Ann: Becoming a substantial holder

AVR Ann: FDA Allows Manufacturing to Begin at Expanded Facility

AVR Ann: Presentation at NWR Virtual Healthcare Conference

AVR Ann: Application for quotation of securities - AVR

AVR Ann: NWR Virtual Healthcare Conference

AVR Ann: Notice of AGM Date and Closing of Nominations for Directors

AVR Ann: S&P DJI Announces March 2023 Quarterly Rebalance

AVR Ann: Preliminary Final Report

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: Cleansing Notice

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Settlement of $35M Capital Raising Transaction

AVR Ann: Change in substantial holding

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: FDA Grants Expanded Approval for the DurAVR EFS

AVR Ann: Proposed issue of securities - AVR

AVR Ann: $35M Capital Raise

AVR Ann: Trading Halt

AVR Ann: Pause in Trading

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Proposed $50 Million Capital Facility

AVR Ann: Trading Halt

AVR Ann: Pause in Trading

AVR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

AVR Ann: DurAVR First in Human Study 12 Month Results

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: Cleansing Notice

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: FDA Approves Early Feasibility Study for DurAVR THV System

AVR Ann: Anteris DurAVR Comparative Study - PCR London Valves

AVR Ann: Anteris DurAVR presented at PCR London Valves

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

AVR Ann: R&D Refund

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: Anteris Investor Webinar

Register to track AVR and receive email alerts.

Similar Companies

ANN
MGZ
NAN
NXS
OSX
PNV
SDI
SDI